Source:http://linkedlifedata.com/resource/pubmed/id/18575272
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:dateCreated |
2008-6-25
|
pubmed:abstractText |
Eukaryotic and prokaryotic chaperonin 60s (Cpn60s) activate macrophages to produce pro-inflammatory cytokines. CD14 and TLR4 have been proposed as potential Cpn receptors. In addition, Cpn60s can block LPS-induced activation. This is a dose-related effect, low concentrations block, and high concentrations activate. This may relate to the ability of Cpn60s to block inflammatory disease. Cpns are multiplex or moon-lighting proteins, with functions as molecular chaperones, in stress survival and as inflammatory modulators. A cpn60.1 knockout mutant does not induce a granulomatous response and cytokine levels, such as tumour necrosis factor are reduced in the tissues. These data suggest that Cpn60.1 may also function as a virulence factor.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
1528-2511
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
291
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
160-9; discussion 169-72, 221-4
|
pubmed:meshHeading |
pubmed-meshheading:18575272-Chaperonin 60,
pubmed-meshheading:18575272-Granuloma,
pubmed-meshheading:18575272-Humans,
pubmed-meshheading:18575272-Immunologic Factors,
pubmed-meshheading:18575272-Immunosuppression,
pubmed-meshheading:18575272-Macrophage Activation,
pubmed-meshheading:18575272-Receptors, Cell Surface
|
pubmed:year |
2008
|
pubmed:articleTitle |
Chaperonin 60 and macrophage activation.
|
pubmed:affiliation |
Medical Microbiology, Centre for Infection, Department of Cellular and Molecular Medicine, St George's, University of London, Cranmer Terrace, London SW17 0RE, UK.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|